Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BIIBBIIB
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BIOGEN INC

Yes. Goldman Sachs holds 1,230,390 shares of BIIB (Biogen), worth $265.8M, as of its Q2 2026 13F filing. It increased the position by 179,296 shares (+17.1%) from Q1 2026. Goldman Sachs has held BIIB in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$265.8M

Current Shares

1.2M

Total Value Change

+$74.1M

Total Shares Change

+241,349

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+17.1%
$265.8M0.0%$216.06
36
2026-Q1
Decreased
1.1M
-4.4%
$192.7M0.0%$183.33
0
2025-Q4
Increased
1.1M
+3.4%
$193.5M0.0%$175.99
32
2025-Q3
Increased
1.1M
+58.5%
$149M0.0%$140.08
43
2025-Q2
Increased
670,852
+10.9%
$84.3M0.0%$125.59
33
2025-Q1
Decreased
604,697
-21.5%
$82.7M0.0%$136.84
0
2024-Q4
Decreased
770,320
-22.1%
$117.8M0.0%$152.92
0
2024-Q3
Decreased
989,041
-30.4%
$191.7M0.0%$193.84
0

Other major holders of BIIB: PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used